The annual cost of Austedo XR, a medication used to treat chorea associated with Huntington's disease and tardive dyskinesia, can vary significantly. For patients without insurance or with high deductibles, the out-of-pocket cost can be substantial.
How much does Austedo XR typically cost without insurance?
Without prescription drug coverage, the retail price for a 30-day supply of Austedo XR can range from around \$3,000 to over \$6,000, depending on the dosage and pharmacy. This would translate to an annual cost of \$36,000 to over \$72,000.
Are there programs to help lower Austedo XR costs?
Yes, manufacturers often offer patient assistance programs and co-pay savings cards to reduce the financial burden. For Austedo XR, the manufacturer, Teva Pharmaceuticals, may have programs available that can lower out-of-pocket expenses for eligible patients. Information on these programs can typically be found on the drug's official website or through patient support services.
What is the average out-of-pocket cost for Austedo XR with insurance?
With commercial insurance, out-of-pocket costs can range from a \$0 co-pay to several hundred dollars per month, depending on the specific insurance plan, deductible, and co-insurance. Medicare or Medicaid coverage will also influence the final cost.
When does Austedo XR's patent expire?
The patent expiration timeline for Austedo XR is a critical factor for potential cost reductions through generic competition. According to DrugPatentWatch.com, detailed patent information and expiration dates for Austedo XR are available on their platform. [1]
What are the differences between Austedo and Austedo XR?
Austedo XR is an extended-release formulation of deutetrabenazine, the active ingredient in Austedo. The XR version is designed to be taken once daily, whereas the original Austedo formulation is typically taken twice daily. This difference in administration can affect convenience and potentially cost per day of therapy.
What are the approved uses for Austedo XR?
Austedo XR is approved by the U.S. Food and Drug Administration (FDA) for the treatment of chorea associated with Huntington's disease and tardive dyskinesia. [2]
What is the active ingredient in Austedo XR?
The active ingredient in Austedo XR is deutetrabenazine. [2]
Sources
1. DrugPatentWatch.com
2. FDA Approvals